A multiple imputation approach for the evaluation of surrogate markers in the principal stratification causal inference framework
From MaRDI portal
(Redirected from Publication:4984852)
Recommendations
- Evaluating Candidate Principal Surrogate Endpoints
- Comparing biomarkers as principal surrogate endpoints
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling
- Related Causal Frameworks for Surrogate Outcomes
Cites work
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- A case-cohort design for epidemiologic cohort studies and disease prevention trials
- Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Comparing biomarkers as principal surrogate endpoints
- Direct and Indirect Causal Effects via Potential Outcomes*
- Evaluating Candidate Principal Surrogate Endpoints
- scientific article; zbMATH DE number 2140075 (Why is no real title available?)
- Multiple imputation approaches for the analysis of dichotomized responses in longitudinal studies with missing data
- Multiple imputation methods for multivariate one-sided tests with missing data
- Principal stratification in causal inference
- Related Causal Frameworks for Surrogate Outcomes
- Simple relations between principal stratification and direct and indirect effects
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
- The Robust Inference for the Cox Proportional Hazards Model
Cited in
(7)- Comparing biomarkers as principal surrogate endpoints
- Evaluating correlation-based metric for surrogate marker qualification within a causal correlation framework
- A Bayesian approach to surrogacy assessment using principal stratification in clinical trials
- A unified evaluation of differential vaccine efficacy
- Semiparametric pseudo-score and pseudo-likelihood for evaluating correlate of protection in vaccine trials
- Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpoints
- Validation of surrogate endpoints in cancer clinical trials via principal stratification with an application to a prostate cancer trial
This page was built for publication: A multiple imputation approach for the evaluation of surrogate markers in the principal stratification causal inference framework
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4984852)
